62 results
Page 2 of 4
6-K
EX-99.1
x9u2owc8kdk72
21 Sep 23
NewAmsterdam Pharma Announces Initial Data from Phase 2a Clinical Trial Evaluating Obicetrapib in Patients
7:14am
6-K
EX-99.1
vnoom4vh3c 8twzx0o
28 Aug 23
Current report (foreign)
4:16pm
424B3
kfa30muuoijn4i5gvv
15 Aug 23
Prospectus supplement
4:52pm
6-K
EX-99.2
z1omsmai4cj63trr
14 Aug 23
NewAmsterdam Pharma Announces Appointment of William “BJ” Jones, formerly of Biohaven Pharmaceuticals, as Chief Commercial Officer
4:52pm
POS AM
qr9kftup8
7 Aug 23
Prospectus update (post-effective amendment)
7:56am
6-K
EX-99.1
wwr3yzj 2p
7 Aug 23
NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter 2023 Financial Highlights
7:38am
6-K
EX-99.2
hpgb8gz29p4sn
7 Aug 23
Research and development expenses
7:24am
6-K
EX-99
rueq5ao8g37ev9bgo
26 Jul 23
NewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3 BROADWAY Clinical Trial Evaluating
8:00am
424B3
4vuk8qsr3rn577
9 Jun 23
Prospectus supplement
9:43pm
6-K
EX-1.1
myvlif1q zup
9 Jun 23
Current report (foreign)
9:39pm
6-K
EX-99.1
gok5sdd6bqlx1fi
9 Jun 23
Current report (foreign)
9:39pm
424B3
aox9hndj
8 Jun 23
Prospectus supplement
5:01pm
424B3
d7u3udh 4t
6 Jun 23
Prospectus supplement
4:20pm
6-K
EX-99.3
wutuersuoi gtpxh47t
5 Jun 23
Current report (foreign)
8:50am
6-K
EX-99.2
9hx86de pwsfm
5 Jun 23
Current report (foreign)
8:50am
6-K
EX-99.1
nbep206k 3h
5 Jun 23
Current report (foreign)
8:50am
424B3
fjq hqon5i
23 May 23
Prospectus supplement
8:14am
6-K
EX-99.1
acuya6x3n53
23 May 23
NewAmsterdam to Present Full Data from ROSE2 at NLA Scientific Sessions 2023
8:11am
424B3
j8mzhauano5mmpkk
8 May 23
Prospectus supplement
8:33am
6-K
EX-99.1
au5pzlev0kikfz
8 May 23
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Highlights
8:30am